<p>德意志银行（Deutsche Bank Aktiengesellschaft）的股票分析师在周二向投资者发布的报告中，将 Teladoc Health（纽约证券交易所代码：TDOC - 获取免费报告）的评级从 “持有” 上调至 “买入”。该券商目前对该健康服务提供商的股票设定了 11.00 美元的目标价。德意志银行的目标价意味着该股票有 107.35% 的潜在上涨空间，较其前一交易日收盘价而言。</p>
<p>获取 <strong>Teladoc Health</strong> 的提醒：</p>
<ul>
<li>2 只可能受益于特朗普新任 FDA 官员的远程医疗股票</li>
</ul>
<p>其他几位股票分析师也最近对该股票发表了评论。Oppenheimer 将 Teladoc Health 的目标价从 12.00 美元下调至 7.00 美元，并在 3 月 3 日的报告中给予该股票 “跑赢大盘” 的评级。Canaccord Genuity Group 将 Teladoc Health 的目标价从 12.00 美元下调至 10.00 美元，并在 2 月 26 日的报告中给予该股票 “买入” 评级。富国银行（Wells Fargo &amp; Company）在 2 月 26 日的研究报告中将 Teladoc Health 的目标价从 8.00 美元下调至 6.00 美元，并给予该股票 “持平” 的评级。巴克莱（Barclays）在 12 月 9 日的研究报告中开始覆盖 Teladoc Health 的股票，给予 “持平” 评级和 8.50 美元的目标价。最后，花旗集团（Citigroup）在 3 月 3 日的研究报告中将 Teladoc Health 的目标价从 9.00 美元下调至 6.00 美元，并给予该公司的 “中性” 评级。六位研究分析师对该股票给予了 “买入” 评级，十三位给予了 “持有” 评级，一位给予了 “卖出” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “持有”，共识目标价为 7.76 美元。</p>
<p><strong>查看我们关于 Teladoc Health 的最新报告</strong></p>
<h2>Teladoc Health 价格表现</h2>
<ul>
<li>2 只曾经的疫情明星股票瞄准 2025 年的大反转</li>
</ul>
<p>周二，纽约证券交易所 TDOC 的开盘价为 5.31 美元。该公司的 50 日移动平均价格为 5.75 美元，200 日移动平均价格为 7.11 美元。该公司的速动比率为 2.67，流动比率为 2.77，债务与股本比率为 0.72。该股票的市值为 9.4641 亿美元，市盈率为-4.65，贝塔值为 2.13。Teladoc Health 的 12 个月低点为 4.40 美元，12 个月高点为 9.77 美元。</p>
<p>Teladoc Health（纽约证券交易所代码：TDOC - 获取免费报告）最近在 2 月 25 日发布了季度财报。该健康服务提供商报告的每股收益（EPS）为-0.14 美元，超出分析师的共识预期（-0.19 美元）0.05 美元。Teladoc Health 的净利润率为-7.92%，股本回报率为-9.13%。该公司在本季度的收入为 6.4227 亿美元，超过了共识预期的 6.3533 亿美元。在去年同期，该公司的每股收益为-0.28 美元。该公司的季度收入同比增长 0.3%。Teladoc Health 已将其 2026 年第一季度的指导目标设定为-0.450 至-0.350 美元的每股收益，并将其 2026 财年的指导目标设定为-1.100 至-0.700 美元的每股收益。作为一个整体，股票分析师预测 Teladoc Health 在当前财年的每股收益为-1.16 美元。</p>
<h2>Teladoc Health 的内部活动</h2>
<ul>
<li>新任首席执行官能否复兴这只挣扎的远程医疗股票？</li>
</ul>
<p>在其他 Teladoc Health 的新闻中，首席执行官 Charles Divita III 在 12 月 11 日的交易中出售了 17,138 股该股票。股份以平均价格 7.63 美元出售，总价值为 130,762.94 美元。出售后，首席执行官直接持有该公司 201,036 股股份，价值 1,533,904.68 美元。这代表其持股比例下降了 7.86%。该交易已在向 SEC 提交的文件中披露，文件可通过此链接获取。公司内部人士持有该公司 0.58% 的股份。</p>
<h2>Teladoc Health 的机构交易</h2>
<p>一些对冲基金最近对该公司的持仓进行了调整。先锋集团（Vanguard Group Inc.）在第三季度将其在 Teladoc Health 的持仓提高了 4.2%。先锋集团目前持有该健康服务提供商 21,910,950 股股票，价值 169,372,000 美元，此前在上个季度增持了 891,732 股。Dimensional Fund Advisors LP 在第四季度将其在 Teladoc Health 的持仓提高了 8.8%。Dimensional Fund Advisors LP 目前持有该健康服务提供商 7,494,255 股股票，价值 52,459,000 美元，此前在上个季度增持了 605,061 股。Geode Capital Management LLC 在第四季度将其在 Teladoc Health 的持仓提高了 0.4%。Geode Capital Management LLC 目前持有该健康服务提供商 4,188,313 股股票，价值 29,324,000 美元，此前在上个季度增持了 18,394 股。Jupiter Asset Management Ltd.在第四季度将其在 Teladoc Health 的持仓提高了 293.9%。Jupiter Asset Management Ltd.目前持有该健康服务提供商 3,860,076 股股票，价值 27,021,000 美元，此前在该期间增持了 2,880,008 股。最后，Nuveen LLC 在第四季度将其在 Teladoc Health 的持仓提高了 38.7%。Nuveen LLC 目前持有该健康服务提供商 2,659,662 股股票，价值 18,618,000 美元，此前在上个季度增持了 742,240 股。76.82% 的股票由机构投资者和对冲基金持有。</p>
<h2>Teladoc Health 公司简介</h2>
<p>（获取免费报告）</p>
<p>Teladoc Health, Inc 是一家领先的全球虚拟医疗服务提供商，通过电话、视频和移动应用平台提供按需医疗咨询。该公司将患者与持牌医生和专家连接，处理非紧急医疗问题、心理健康支持、皮肤病学和慢性病管理。通过利用数字技术和数据分析，Teladoc 旨在提高可及性，降低医疗成本，并通过个性化护理计划和远程监测改善患者的治疗效果。</p>
<p>Teladoc 的服务组合包括普通医疗访问、心理健康会话、复杂病例的专家医疗服务，以及旨在支持慢性病管理（如糖尿病、高血压和心脏病）的健康计划。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们认为比 Teladoc Health 更好的股票</li>
<li>在 2026 年 5 月 15 日之前购买这只黄金股票</li>
<li>阅读此文，否则将永远后悔</li>
<li>摩根大通正在押注这枚币</li>
<li>中央银行刚刚做了一件自 1967 年以来未曾做过的事情</li>
<li>我的爱泼斯坦故事</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRET0M?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRET0M"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Teladoc Health 吗？</h2>
<p>在考虑 Teladoc Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Teladoc Health 并不在名单上。</p>
<p>虽然 Teladoc Health 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

HEAL

TDOC

远程医疗和数字健康 ETF - GlobalX

FDHT

<p>德意志银行股份公司将 Teladoc Health（纽约证券交易所代码：TDOC）的评级从 “持有” 上调至 “买入”，设定目标价为 11.00 美元，意味着潜在上涨空间为 107.35%。其他分析师的看法各异，Oppenheimer 将目标价下调至 7.00 美元，Canaccord Genuity 则下调至 10.00 美元。目前，Teladoc 的共识评级为 “持有”，目标价为 7.76 美元。该股票开盘价为 5.31 美元，市值为 9.4641 亿美元，最近一个季度的每股收益为（0.14 美元），超出预期。首席执行官 Charles Divita III 出售了部分股份，减少了其持股比例 7.86%</p>

<p>Teladoc Health (NYSE:TDOC - Get Free Report) was upgraded by stock analysts at Deutsche Bank Aktiengesellschaft from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a note issued to investors on Tuesday, Marketbeat.com reports. The brokerage presently has a $11.00 target price on the health services provider's stock. Deutsche Bank Aktiengesellschaft's price target points to a potential upside of 107.35% from the stock's previous close.</p>
<div class="lb-trans"><p>德意志银行（Deutsche Bank Aktiengesellschaft）的股票分析师在周二向投资者发布的报告中，将 Teladoc Health（纽约证券交易所代码：TDOC - 获取免费报告）的评级从 “持有” 上调至 “买入”。该券商目前对该健康服务提供商的股票设定了 11.00 美元的目标价。德意志银行的目标价意味着该股票有 107.35% 的潜在上涨空间，较其前一交易日收盘价而言。</p>
</div><p>Get <strong>Teladoc Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Teladoc Health</strong> 的提醒：</p>
</div><ul>
<li>2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只可能受益于特朗普新任 FDA 官员的远程医疗股票</li>
</ul>
</div><p>Several other equities analysts also recently commented on the stock. Oppenheimer lowered their target price on shares of Teladoc Health from $12.00 to $7.00 and set an &#34;outperform&#34; rating on the stock in a report on Tuesday, March 3rd. Canaccord Genuity Group lowered their target price on shares of Teladoc Health from $12.00 to $10.00 and set a &#34;buy&#34; rating on the stock in a report on Thursday, February 26th. Wells Fargo &amp; Company decreased their price target on Teladoc Health from $8.00 to $6.00 and set an &#34;equal weight&#34; rating on the stock in a research note on Thursday, February 26th. Barclays assumed coverage on shares of Teladoc Health in a research report on Tuesday, December 9th. They set an &#34;equal weight&#34; rating and a $8.50 price target for the company. Finally, Citigroup dropped their price objective on shares of Teladoc Health from $9.00 to $6.00 and set a &#34;neutral&#34; rating for the company in a research note on Tuesday, March 3rd. Six research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of &#34;Hold&#34; and a consensus price target of $7.76.</p>
<div class="lb-trans"><p>其他几位股票分析师也最近对该股票发表了评论。Oppenheimer 将 Teladoc Health 的目标价从 12.00 美元下调至 7.00 美元，并在 3 月 3 日的报告中给予该股票 “跑赢大盘” 的评级。Canaccord Genuity Group 将 Teladoc Health 的目标价从 12.00 美元下调至 10.00 美元，并在 2 月 26 日的报告中给予该股票 “买入” 评级。富国银行（Wells Fargo &amp; Company）在 2 月 26 日的研究报告中将 Teladoc Health 的目标价从 8.00 美元下调至 6.00 美元，并给予该股票 “持平” 的评级。巴克莱（Barclays）在 12 月 9 日的研究报告中开始覆盖 Teladoc Health 的股票，给予 “持平” 评级和 8.50 美元的目标价。最后，花旗集团（Citigroup）在 3 月 3 日的研究报告中将 Teladoc Health 的目标价从 9.00 美元下调至 6.00 美元，并给予该公司的 “中性” 评级。六位研究分析师对该股票给予了 “买入” 评级，十三位给予了 “持有” 评级，一位给予了 “卖出” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “持有”，共识目标价为 7.76 美元。</p>
</div><p><strong>Check Out Our Latest Report on Teladoc Health</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Teladoc Health 的最新报告</strong></p>
</div><h2>Teladoc Health Price Performance</h2>
<div class="lb-trans"><h2>Teladoc Health 价格表现</h2>
</div><ul>
<li>2 Former Pandemic Darlings Eyeing a Big 2025 Turnaround</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只曾经的疫情明星股票瞄准 2025 年的大反转</li>
</ul>
</div><p>NYSE TDOC opened at $5.31 on Tuesday. The company has a 50 day moving average price of $5.75 and a two-hundred day moving average price of $7.11. The company has a quick ratio of 2.67, a current ratio of 2.77 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $946.41 million, a PE ratio of -4.65 and a beta of 2.13. Teladoc Health has a 12-month low of $4.40 and a 12-month high of $9.77.</p>
<div class="lb-trans"><p>周二，纽约证券交易所 TDOC 的开盘价为 5.31 美元。该公司的 50 日移动平均价格为 5.75 美元，200 日移动平均价格为 7.11 美元。该公司的速动比率为 2.67，流动比率为 2.77，债务与股本比率为 0.72。该股票的市值为 9.4641 亿美元，市盈率为-4.65，贝塔值为 2.13。Teladoc Health 的 12 个月低点为 4.40 美元，12 个月高点为 9.77 美元。</p>
</div><p>Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 25th. The health services provider reported ($0.14) EPS for the quarter, topping analysts' consensus estimates of ($0.19) by $0.05. Teladoc Health had a negative net margin of 7.92% and a negative return on equity of 9.13%. The company had revenue of $642.27 million during the quarter, compared to the consensus estimate of $635.33 million. During the same period in the prior year, the business posted ($0.28) EPS. The company's quarterly revenue was up .3% on a year-over-year basis. Teladoc Health has set its Q1 2026 guidance at -0.450--0.350 EPS and its FY 2026 guidance at -1.100--0.700 EPS. As a group, equities analysts predict that Teladoc Health will post -1.16 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Teladoc Health（纽约证券交易所代码：TDOC - 获取免费报告）最近在 2 月 25 日发布了季度财报。该健康服务提供商报告的每股收益（EPS）为-0.14 美元，超出分析师的共识预期（-0.19 美元）0.05 美元。Teladoc Health 的净利润率为-7.92%，股本回报率为-9.13%。该公司在本季度的收入为 6.4227 亿美元，超过了共识预期的 6.3533 亿美元。在去年同期，该公司的每股收益为-0.28 美元。该公司的季度收入同比增长 0.3%。Teladoc Health 已将其 2026 年第一季度的指导目标设定为-0.450 至-0.350 美元的每股收益，并将其 2026 财年的指导目标设定为-1.100 至-0.700 美元的每股收益。作为一个整体，股票分析师预测 Teladoc Health 在当前财年的每股收益为-1.16 美元。</p>
</div><h2>Insider Activity at Teladoc Health</h2>
<div class="lb-trans"><h2>Teladoc Health 的内部活动</h2>
</div><ul>
<li>Can the New CEO Revive This Struggling Telehealth Stock?</li>
</ul>
<div class="lb-trans"><ul>
<li>新任首席执行官能否复兴这只挣扎的远程医疗股票？</li>
</ul>
</div><p>In other Teladoc Health news, CEO Charles Divita III sold 17,138 shares of the stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $7.63, for a total value of $130,762.94. Following the sale, the chief executive officer directly owned 201,036 shares in the company, valued at $1,533,904.68. This represents a 7.86% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.58% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Teladoc Health 的新闻中，首席执行官 Charles Divita III 在 12 月 11 日的交易中出售了 17,138 股该股票。股份以平均价格 7.63 美元出售，总价值为 130,762.94 美元。出售后，首席执行官直接持有该公司 201,036 股股份，价值 1,533,904.68 美元。这代表其持股比例下降了 7.86%。该交易已在向 SEC 提交的文件中披露，文件可通过此链接获取。公司内部人士持有该公司 0.58% 的股份。</p>
</div><h2>Institutional Trading of Teladoc Health</h2>
<div class="lb-trans"><h2>Teladoc Health 的机构交易</h2>
</div><p>A number of hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. raised its position in shares of Teladoc Health by 4.2% during the third quarter. Vanguard Group Inc. now owns 21,910,950 shares of the health services provider's stock worth $169,372,000 after acquiring an additional 891,732 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Teladoc Health by 8.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 7,494,255 shares of the health services provider's stock worth $52,459,000 after purchasing an additional 605,061 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Teladoc Health by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 4,188,313 shares of the health services provider's stock valued at $29,324,000 after buying an additional 18,394 shares in the last quarter. Jupiter Asset Management Ltd. increased its holdings in shares of Teladoc Health by 293.9% in the 4th quarter. Jupiter Asset Management Ltd. now owns 3,860,076 shares of the health services provider's stock valued at $27,021,000 after acquiring an additional 2,880,008 shares during the period. Finally, Nuveen LLC boosted its holdings in Teladoc Health by 38.7% during the fourth quarter. Nuveen LLC now owns 2,659,662 shares of the health services provider's stock worth $18,618,000 after buying an additional 742,240 shares in the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一些对冲基金最近对该公司的持仓进行了调整。先锋集团（Vanguard Group Inc.）在第三季度将其在 Teladoc Health 的持仓提高了 4.2%。先锋集团目前持有该健康服务提供商 21,910,950 股股票，价值 169,372,000 美元，此前在上个季度增持了 891,732 股。Dimensional Fund Advisors LP 在第四季度将其在 Teladoc Health 的持仓提高了 8.8%。Dimensional Fund Advisors LP 目前持有该健康服务提供商 7,494,255 股股票，价值 52,459,000 美元，此前在上个季度增持了 605,061 股。Geode Capital Management LLC 在第四季度将其在 Teladoc Health 的持仓提高了 0.4%。Geode Capital Management LLC 目前持有该健康服务提供商 4,188,313 股股票，价值 29,324,000 美元，此前在上个季度增持了 18,394 股。Jupiter Asset Management Ltd.在第四季度将其在 Teladoc Health 的持仓提高了 293.9%。Jupiter Asset Management Ltd.目前持有该健康服务提供商 3,860,076 股股票，价值 27,021,000 美元，此前在该期间增持了 2,880,008 股。最后，Nuveen LLC 在第四季度将其在 Teladoc Health 的持仓提高了 38.7%。Nuveen LLC 目前持有该健康服务提供商 2,659,662 股股票，价值 18,618,000 美元，此前在上个季度增持了 742,240 股。76.82% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Teladoc Health Company Profile</h2>
<div class="lb-trans"><h2>Teladoc Health 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.</p>
<div class="lb-trans"><p>Teladoc Health, Inc 是一家领先的全球虚拟医疗服务提供商，通过电话、视频和移动应用平台提供按需医疗咨询。该公司将患者与持牌医生和专家连接，处理非紧急医疗问题、心理健康支持、皮肤病学和慢性病管理。通过利用数字技术和数据分析，Teladoc 旨在提高可及性，降低医疗成本，并通过个性化护理计划和远程监测改善患者的治疗效果。</p>
</div><p>Teladoc's service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.</p>
<div class="lb-trans"><p>Teladoc 的服务组合包括普通医疗访问、心理健康会话、复杂病例的专家医疗服务，以及旨在支持慢性病管理（如糖尿病、高血压和心脏病）的健康计划。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Teladoc Health</li>
<li>Buy this Gold Stock Before May 15th, 2026</li>
<li>Read this or regret it forever</li>
<li>J.P. Morgan is betting on this coin</li>
<li>Central banks just did something they haven’t done since 1967</li>
<li>My Epstein Story</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 Teladoc Health 更好的股票</li>
<li>在 2026 年 5 月 15 日之前购买这只黄金股票</li>
<li>阅读此文，否则将永远后悔</li>
<li>摩根大通正在押注这枚币</li>
<li>中央银行刚刚做了一件自 1967 年以来未曾做过的事情</li>
<li>我的爱泼斯坦故事</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRET0M" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=TDOC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Teladoc Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Teladoc Health 吗？</h2>
</div><p>Before you consider Teladoc Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Teladoc Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Teladoc Health 并不在名单上。</p>
</div><p>While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Teladoc Health 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Teladoc Health（NYSE 代码：TDOC）在德意志银行股份公司获得评级上调